Uracil compounds and their use
A compound, C1-C6 technology, used in applications, organic chemistry, animal repellants, etc., to solve problems such as insufficient performance and no toxicity to crops
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0667] Production Example 1: Production of compounds 1-12 of the present invention
[0668] Make 109mg 2-chloro-4-fluoro-5-[3-methyl-2,6-dioxo-4-(trifluoromethyl)-1,2,3,6-tetrahydropyrimidin-1-yl ]Phenol and 70mg 2-chloro-5-[1-(methoxycarbonyl)ethoxy]pyrimidine were dissolved in 1.0ml dimethyl sulfoxide, and 10mg copper(I) bromide and 12mg anhydrous lithium carbonate were added to the solution , And the mixture was stirred at 120°C for 2 hours. The reaction solution was cooled to room temperature, and then, the solution was poured into ice water, and extracted with ethyl acetate. The organic layer was washed with saturated brine, dried over anhydrous magnesium sulfate, and concentrated. The residue was subjected to silica gel column chromatography to obtain 10 mg of 2-([2-{2-chloro-4-fluoro-5-[3-methyl-2,6-dioxo-4-(trifluoromethyl)- 1,2,3,6-Tetrahydropyrimidin-1-yl]phenoxy}pyrimidin-5-yl]oxy)methyl propionate [Compound 1-12 of the present invention].
[0669] 1 H-NMR(CDCl 3 / 300MH...
Embodiment 2
[0673] Production Example 2: Production of Compound 7-125 of the present invention
[0674] 0.30g 3-{2-chloro-4-fluoro-5-[3-methyl-2,6-dioxo-4-(trifluoromethyl)-1,2,3,6-tetrahydropyrimidine -1-yl]phenoxy}-2-(methoxycarbonyl)methoxypyridine [the present compound 7-7], a mixture of 0.06g sodium carbonate and 3.0ml c-pentanol was stirred at 100°C for 1.5 hours, It was then stirred at 120°C for 2 hours. The reaction solution was cooled to room temperature, then poured into water, and extracted with ethyl acetate. The organic layer was washed with saturated brine, dried over anhydrous magnesium sulfate, and concentrated. The residue was subjected to silica gel column chromatography to obtain 0.15 g of 3-{2-chloro-4-fluoro-5-[3-methyl-2,6-dioxo-4-(trifluoromethyl)-1,2 , 3,6-Tetrahydropyrimidin-1-yl]phenoxy}-2-(c-pentoxycarbonyl)methoxypyridine [Compound 7-12 of the present invention].
[0675] 1 H-NMR(CDCl 3 / 300MHz)δ(ppm): 1.5-1.9(m, 8H), 3.50(q, 3H, J=1.1Hz), 4.7-5.0(m, 2H), 5.1-5.2(m...
Embodiment 3
[0676] Production Example 3: Production of compound 1-2 of the present invention
[0677] Make 339mg 2-chloro-4-fluoro-5-[3-methyl-2,6-dioxo-4-(trifluoromethyl)-1,2,3,6-tetrahydropyrimidin-1-yl ] Phenol and 217 mg of 2-chloro-4-{1-(methoxycarbonyl)ethoxy]pyrimidine were dissolved in 2ml of N,N-dimethylformamide, 150mg of potassium carbonate was added to this solution, and the mixture was stirred at 80°C 2 hours. The reaction solution was cooled to room temperature, and then the reaction solution was poured into ice water and extracted with ethyl acetate. The organic layer was washed with saturated brine, dried over anhydrous magnesium sulfate, and concentrated. The residue was subjected to silica gel column chromatography to obtain 256 mg of 2-([2-{2-chloro-4-fluoro-5-[3-methyl-2,6-dioxo-4-(trifluoromethyl)- 1,2,3,6-Tetrahydropyrimidin-1-yl]phenoxy}pyrimidin-4-yl]oxy)methyl propionate [Compound 1-2 of the present invention].
[0678] 1 H-NMR(CDCl 3 / 300MHz)δ(ppm): 1.56(d, 3H, J=7....
PUM
| Property | Measurement | Unit |
|---|---|---|
| melting point | aaaaa | aaaaa |
| melting point | aaaaa | aaaaa |
| melting point | aaaaa | aaaaa |
Abstract
Description
Claims
Application Information
Login to View More 
